A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis
Status:
Withdrawn
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the tolerability of treatment with human
lactoferrin 1-11 peptide (hLF1-11) administered intravenously as a single dose given for 10
consecutive days, to patients with bacteremia due to staphylococcus epidermidis.